Literature DB >> 19111024

Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001.

Mohammad-Ali Mohagheghi1, Alireza Mosavi-Jarrahi, Reza Malekzadeh, Max Parkin.   

Abstract

BACKGROUND: There are no population-based data available for cancer in Tehran, a city that includes almost 10% of the Iranian population. This is the first report of cancer incidence in Tehran from a population-based cancer registry for the period of 1998-2001.
METHODS: The cancer registry collects data on all new cases of cancer diagnosed in the resident population of Tehran metropolitan area. Data collection is active and trained abstractors visit close to 120 data sources comprising cancer diagnostic laboratories, secondary- and tertiary-care hospitals, and imaging centers to abstract cancer cases.
RESULTS: During the period of 1998-2001, a total of 34,318 eligible cases were abstracted of which 24% were identified just by death certificates. The overall age-standardized rates (ASR) (adjusted to the world population structure) were 163.0 per 100,000 males and 141.8 per 100,000 females. The most frequently reported malignancies in males were stomach cancer (ASR 19.8), followed by cancers of the prostate (ASR 15.6), lung (ASR 14.9), bladder (ASR 13.3), non-Hodgkin's lymphoma (ASR 7.1), and esophagus (ASR 6.8). In females, the most frequently reported malignancies were breast cancer (ASR 31.4), followed by cancers of the stomach (ASR 10.0), lung (ASR 7.0), ovary (ASR 6.8), and esophagus (ASR 5.3).
CONCLUSION: The data reported by the Tehran Cancer Registry provide information on the cancer profile in Tehran metropolitan area. It clearly shows the breast and stomach, prostate, and tobacco-related cancers as major cancer in this population. The observed cancer rates indicate that Helicobacter pylori eradication, tobacco control measures, and early detection of breast cancer are of importance for cancer control in this population.

Entities:  

Mesh:

Year:  2009        PMID: 19111024

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  53 in total

1.  Honey and apoptosis in human gastric mucosa.

Authors:  Aida Ghaffari; Mohammad H Somi; Abdolrasoul Safaiyan; Jabiz Modaresi; Alireza Ostadrahimi
Journal:  Health Promot Perspect       Date:  2012-07-01

2.  Molecular markers in peripheral blood of Iranian women with breast cancer.

Authors:  Mana Oloomi; Saeid Bouzari; Mohammad-Ali Mohagheghi; Hamideh Khodayaran-Tehrani
Journal:  Cancer Microenviron       Date:  2012-07-25

3.  Helicobacter pylori Omp18 and its application in serologic screening of infection.

Authors:  Yeganeh Talebkhan; Fatemeh Ebrahimzadeh; Maryam Esmaeili; Leili Zamaninia; Azin Nahvijoo; Hossein Khedmat; Forouzandeh Fereidooni; Mohammad Ali Mohagheghi; Marjan Mohammadi
Journal:  Curr Microbiol       Date:  2010-07-23       Impact factor: 2.188

4.  The Incidence of Hepatocellular Carcinoma in Iran from 1996 to 2016: a Systematic Review and Meta-analysis.

Authors:  Soheil Hassanipour; Majid Mohammadzadeh; Fariborz Mansour-Ghanaei; Mohammad Fathalipour; Farahnaz Joukar; Hamid Salehiniya; Elham Abdzadeh; Ali Akbar Samadani; Hossein-Ali Nikbakht; Morteza Arab-Zozani
Journal:  J Gastrointest Cancer       Date:  2019-06

5.  Breast cancer in Wales: time trends and geographical distribution.

Authors:  Ganiy Opeyemi Abdulrahman
Journal:  Gland Surg       Date:  2014-11

6.  Cancers in Eastern Libya: first results from Benghazi Medical Center.

Authors:  Zuhir Bodalal; Raouf Azzuz; Riyad Bendardaf
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

7.  Impact of methylenetetrahydrofolate reductase C677T polymorphism on the risk of gastric cancer and its interaction with Helicobacter pylori infection.

Authors:  Samaneh Saberi; Kazem Zendehdel; Sahar Jahangiri; Yeganeh Talebkhan; Afshin Abdirad; Nazanin Mohajerani; Maryam Bababeik; Najmeh Karami; Maryam Esmaili; Akbar Oghalaie; Parisa Hassanpour; Neda Amini; Mohammad Ali Mohagheghi; Mahmoud Eshagh Hossieni; Marjan Mohammadi
Journal:  Iran Biomed J       Date:  2012

8.  Incidence of Esophageal Cancer in Iran, a Population-Based Study: 2001-2015.

Authors:  Rahmatollah Moradzadeh; Parvaneh Golmohammadi; Bahman Ghaitasi; Haidar Nadrian; Athareh Najafi
Journal:  J Gastrointest Cancer       Date:  2019-09

9.  Epidemiology and trend of cancer in Isfahan 2005-2010.

Authors:  Fariborz Mokarian; Mohammad Arash Ramezani; Kamal Heydari; Maryam Tabatabaeian; Hossein Tavazohi
Journal:  J Res Med Sci       Date:  2011-09       Impact factor: 1.852

10.  Do Clinical and Demographic Features of Patients with Upper-Gastrointestinal Cancer Affect their Health-related Quality of Life?

Authors:  Ramezan-Ali Esmaili-Hesari; Fatemeh Homai-Shandiz; Abbas Motevallian; Zahra Madjd; Masoud Solaymani-Dodaran; Mohsen Asadi-Lari
Journal:  Int J Prev Med       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.